Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

CANbridge to Continue CAN008 Phase 2 Trial in Glioblastoma Multiforme (GBM) in China

Tuesday, July 04, 2023

CANbridge Pharmaceuticals has announced its plan to continue the Phase study of CAN asunercept in patients with newly diagnosed glioblastoma multiforme GBM in China based on the recommendation of the independent data monitoring committee

Maruho Enters into Licence Agreement with Alchemedicine

Tuesday, July 04, 2023

Maruho and Alchemedicine announced that they have entered into an exclusive licence agreement to develop and commercialise Alchemedicines aldehyde dehydrogenase ALDH activator

Skyline Therapeutics Announces US FDA Clearance for Phase I/IIa Clinical Trial of SKG0106

Tuesday, July 04, 2023

Skyline Therapeutics has received clearance from the US Food and Drug Administration FDA to proceed with a Phase IIIa clinical trial for their investigational new drug IND called SKG This drug is a onetime intravitreally delivered gene therapy design...

Lifera Enters into Strategic Collaboration with CENTOGENE

Monday, July 03, 2023

CENTOGENE and Lifera announced a strategic collaboration with the establishment of a joint venture JV to improve patient access to quality multiomics locally and regionally in Saudi Arabia and the Gulf Cooperation Council GCC

Innovent Bio and IASO Biotechnology Announced National Medical Products Administration Approval for FUCASO®

Monday, July 03, 2023

Innovent Biologics and IASO Biotechnology announced that the Chinas National Medical Products Administration NMPA has approved the New Drug Application NDA for FUCASO the first fullyhuman BCMA CART Therapy for the treatment of relapsed or refractory...

Vazyme Enters into Global Strategic Collaboration Agreement with Azenta

Saturday, July 01, 2023

Vazyme and Azenta Life Sciences have recently announced a global strategic cooperation agreement

Argenx and Zai Lab Announces Biologics Licence Application (BLA) for VYVGART® (efgartigimod alfa injection)

Saturday, July 01, 2023

Argenx and Zai Lab have announced that the Biologics Licence Application BLA for VYVGART efgartigimod alfa injection has been approved by Chinas National Medical Products Administration NMPA

Chime Biologics Announces Strategic Cooperation with Leads Biolabs and BeiGene

Saturday, July 01, 2023

Chime Biologics Leads Biolabs and BeiGene have formed a strategic cooperation to accelerate the development and manufacturing of LBL a novel antibody targeting the LAG pathway

SK bioscience-Sanofi Announce Positive Results of 21-Valent Pneumococcal Conjugate Vaccine Candidate

Friday, June 30, 2023

SK bioscience and Sanofi announced positive results from Phase II clinical trials of their valent pneumococcal conjugate vaccine candidate known as GBP or SP

Harbour BioMed Accepts Biologics Licence Application of Batoclimab

Friday, June 30, 2023

Harbour BioMed announced the acceptance of the Biologics Licence Application BLA of batoclimab HBM by the National Medical Products Administration NMPA of China for the treatment of generalised myasthenia gravis gMG